Patents for C12P 21 - Preparation of peptides or proteins (112,499)
02/2000
02/02/2000EP0975741A2 Alpha/beta hydrolase-fold enzymes
02/02/2000EP0975739A1 Stimulation, culture and preservation of pancreatic and other cells
02/02/2000EP0975673A2 Determination of recombinant glycosylated proteins and peptides in biological fluids
02/02/2000EP0975672A1 Antibodies for inhibiting blood coagulation and methods of use thereof
02/02/2000EP0975668A1 MODIFIED TNF$g(a) MOLECULES, DNA ENCODING SUCH MODIFIED TNF$g(a) MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNF$g(a) MOLECULES AND DNA
02/02/2000EP0975666A2 Compositions and methods for the treatment and diagnosis of breast cancer
02/02/2000EP0975664A1 Aatt promoter element and transcription factor
02/02/2000EP0975657A1 Method of purifying protein from inclusion bodies
02/02/2000EP0777683B1 Antiprotozoal cyclic tetrapeptides
02/02/2000EP0729580B1 Method of identifying hdm-2-specific antibodies
02/02/2000EP0713532B1 Modified maxadilan protein, its preparation and use, and dna encoding the protein
02/02/2000EP0713529B1 Growth differentiation factor of the TGF-B family
02/02/2000EP0539530B1 Purification directed cloning of peptides
02/02/2000EP0397834B1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants
02/01/2000US6020479 Amino acid transporters and uses
02/01/2000US6020477 DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1β converting enzyme
02/01/2000US6020468 Antibodies directed against binding-associated epitopes
02/01/2000US6020466 Myeloid cell leukemia associated gene mcl-1
02/01/2000US6020464 Isolated Smad protein
02/01/2000US6020462 Nucleic acids encoding the hypoxia inducible factor-1
02/01/2000US6020309 Pharmaceuticals based on papillomaviruses
02/01/2000US6020197 Neuroblasts are dependant upon about 1 to 100 ng/ml of bfgf for long term maintenance.
02/01/2000US6020195 Antibodies against hepatitis G virus and their use for the diagnostic detection of HGV and as a therapeutic agent
02/01/2000US6020192 Genes adapted for high level expression in mammalian cells, especially those of human origin.
02/01/2000US6020189 Fibroblast growth factor homologous factors (FHFs) and methods of use
02/01/2000US6020188 Polynucleotides encoding platelet endothelial cell adhesion molecule (PECAM-1) and fragments thereof
02/01/2000US6020179 Nucleic acids encoding human tyrosine phosphatases
02/01/2000US6020170 Method of preparing a monoclonal antibody
02/01/2000US6020169 Production of secreted foreign polypeptides in plant cell culture
02/01/2000US6020168 Porcine CNP gene and precursor protein
02/01/2000US6020165 Cytikine signal regulators
02/01/2000US6020164 Human RNA binding proteins
02/01/2000US6020163 Lipocalin homolog
02/01/2000US6020161 PIGR-1, a member of immunoglobulin gene superfamily
02/01/2000US6020158 Intracellular g-protein complex which mediates further intracellular signaling activities generally the production of second messengers such as cyclic amp (camp), phospholipase c, inositol triphosphate or ion channel proteins.
02/01/2000US6020157 Polynucleotides encoding HFGAN72X receptor
02/01/2000US6020153 Chimeric antibodies
02/01/2000US6020152 Lymphocyte-associated cell surface protein
02/01/2000US6020144 These organisms have evolved a sophisticated ability to infect a host and evade their host's immune defenses.
02/01/2000US6020143 The invention is concerned with the identification, isolation and cloning of genes which are associated with alzheimer's disease.
02/01/2000US6020142 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders
02/01/2000US6019987 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof
02/01/2000US6019982 Mutant enterotoxin effective as a non-toxic oral adjuvant
02/01/2000US6019980 Nucleic acid respiratory syncytial virus vaccines
02/01/2000US6019973 Vaccine against enterotoxin-induced illness.
02/01/2000CA2218491C Novel methods for the assay of troponin i and t and complexes of troponin i and t and selection of antibodies for use in immunoassays
02/01/2000CA2171982C Drug binding protein
02/01/2000CA2069085C Activatable fibrinolytic and anti-thrombotic proteins
02/01/2000CA2047681C Vaccines for nontypable haemophilus influenzae
02/01/2000CA2035039C Recombinant poxvirus and streptococcal m protein vaccine
02/01/2000CA2009198C Monoclonal antibody for differentiating hiv-2 from hiv-1 seropositive individuals
02/01/2000CA1340888C Vaccines and diagnostic assays for haemophilus influenzae
01/2000
01/27/2000WO2000004172A1 Method of making proteins in transformed yeast cells
01/27/2000WO2000004170A1 Cleavage of caulobacter produced recombinant fusion proteins
01/27/2000WO2000004150A1 Human presenilin-associated protein
01/27/2000WO2000004149A2 Compositions and methods for therapy and diagnosis of prostate cancer
01/27/2000WO2000004148A1 Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia
01/27/2000WO2000004147A1 Differentiation regulatory factor expressed specifically in testis
01/27/2000WO2000004140A1 71 human secreted proteins
01/27/2000WO2000004137A1 Human aspartic proteases
01/27/2000WO2000004045A1 Axor10, a g-protein coupled receptor
01/27/2000WO2000004043A1 Protease susceptibility ii
01/27/2000WO1999061630A3 Chimeric molecules comprising an extracellular ligand binding domain of a receptor and an ige fc or constant region, and their use in an assay system
01/27/2000WO1999060127A3 Il-17 homologous polypeptides and therapeutic uses thereof
01/27/2000WO1999054465A9 Gene encoding syntaxin interacting protein
01/27/2000WO1999023227A9 Hyaluronan synthase gene and uses thereof
01/27/2000CA2337635A1 Method of making proteins in transformed yeast cells
01/27/2000CA2335274A1 Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia
01/27/2000CA2334038A1 Compositions and methods for therapy and diagnosis of prostate cancer
01/27/2000CA2333917A1 71 human secreted proteins
01/27/2000CA2333467A1 Human presenilin-associated protein
01/27/2000CA2303062A1 Human aspartic proteases
01/26/2000EP0974671A1 Method for diagnosing bone dysbolism
01/26/2000EP0974664A2 Human polypeptides and polynucleotides homolog to mouse testes-specific angiotensins converting enzyme
01/26/2000EP0974663A1 Lipoprotein associated phospholipase A2, inhibitors thereof and use of same in diagnosis and therapy
01/26/2000EP0974659A2 Viral nucleotide sequences
01/26/2000EP0974655A2 G-CSF analog compositions and methods
01/26/2000EP0974654A2 Method for secretory production of human growth hormone
01/26/2000EP0974653A2 Human gastric cancer antigen gene and protein
01/26/2000EP0974651A1 Physiologically active protein originating in mammals
01/26/2000EP0974057A1 Methods to detect hk2 polypeptides
01/26/2000EP0973944A1 Reagents and methods useful for detecting diseases of the gastrointestinal tract
01/26/2000EP0973940A1 AN $i(IN VITRO) METHOD FOR CONSTRUCTION OF A DNA LIBRARY
01/26/2000EP0973923A1 IMPROVED ASSAYS FOR $g(b)-AMYLOID PROCESSING
01/26/2000EP0973909A2 Process for extracting and purifying recombinant, non-lipidised osp-protein
01/26/2000EP0973903A2 Protein for inhibiting apoptosis
01/26/2000EP0973900A1 flt3 LIGAND CHIMERIC PROTEINS
01/26/2000EP0973898A2 SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
01/26/2000EP0973897A1 Human tumor-associated membrane protein
01/26/2000EP0973894A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
01/26/2000EP0973892A2 28 human secreted proteins
01/26/2000EP0973890A2 Secreted proteins and polynucleotides encoding them
01/26/2000EP0973889A1 Human calcium channels alfa1 subunits and related probes, cell lines and methods
01/26/2000EP0973884A1 Phosphate-deficiency inducible promoter
01/26/2000EP0973876A1 DNA ENCODING $i(PNEUMOCYSTIS CARINII) PROTEASE
01/26/2000EP0973869A1 Method for increasing the growth of plant cell cultures
01/26/2000EP0973867A1 Cell culture media for enhanced protein production
01/26/2000EP0973805A1 Method for production of antibodies to specific sites of rapamycin
01/26/2000EP0973804A2 Anti-vegf antibodies
01/26/2000EP0973800A1 Novel receptor